Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Payables (2018 - 2026)

Viemed Healthcare filings provide 8 years of Payables readings, the most recent being $7.3 million for Q4 2025.

  • On a quarterly basis, Payables rose 37.79% to $7.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $7.3 million, a 37.79% increase, with the full-year FY2025 number at $7.3 million, up 37.79% from a year prior.
  • Payables hit $7.3 million in Q4 2025 for Viemed Healthcare, down from $8.7 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $8.7 million in Q3 2025 to a low of $2.5 million in Q2 2021.
  • Median Payables over the past 5 years was $5.0 million (2021), compared with a mean of $5.2 million.
  • Biggest five-year swings in Payables: plummeted 60.28% in 2021 and later surged 66.59% in 2023.
  • Viemed Healthcare's Payables stood at $3.2 million in 2021, then dropped by 18.18% to $2.6 million in 2022, then surged by 57.74% to $4.2 million in 2023, then rose by 27.32% to $5.3 million in 2024, then surged by 37.79% to $7.3 million in 2025.
  • The last three reported values for Payables were $7.3 million (Q4 2025), $8.7 million (Q3 2025), and $8.3 million (Q2 2025) per Business Quant data.